Comment on: TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY. Diabetes Care 2013;36:1749-1757

Diabetes Care. 2013 Dec;36(12):e223. doi: 10.2337/dc13-1426.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Resistance / physiology*
  • Insulin-Secreting Cells / physiology*
  • Life Style*
  • Male
  • Metformin / therapeutic use*
  • Thiazoles / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Thiazoles
  • Metformin